Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
28.01.2025 20:12:59

EQS-News: Heliad invests in Gaia, who aim to expand and further improve fertility care with outcome-based financing

FinLab
10.50 EUR 0.00%
Kaufen / Verkaufen

EQS-News: Heliad AG / Key word(s): Investment
Heliad invests in Gaia, who aim to expand and further improve fertility care with outcome-based financing

28.01.2025 / 20:12 CET/CEST
The issuer is solely responsible for the content of this announcement.


Frankfurt am Main, January 28, 2025 – Heliad, through its early-stage investment arm Collective Ventures, has announced its participation in Gaia’s USD 15m funding round. Led by Valar Ventures, the round also includes existing investors such as Atomico, Kindred, Seedcamp, and Clocktower. Together with Valar, Heliad is joining Gaia’s existing investor base to support the company’s mission of improving access to fertility care.

Gaia’s Mission: Building Families with Innovative Accessibility

Every year, 10 million people worldwide face challenges to conceive, yet only 13% can access the care they need due to barriers like cost, stigma, and complexity. Gaia is addressing this gap by becoming the comprehensive approach to fertility treatment. The company offers comprehensive solutions for parenthood, including egg and embryo freezing, IUI, IVF, shared motherhood, donor eggs/sperm, and, in the future, surrogacy and adoption.

Gaia’s value-based care model reduces financial risk for individuals by tying payments to successful outcomes. Using an AI-driven approach with 90% predictive accuracy, Gaia optimizes fertility outcomes while ensuring affordability. Members only pay for results, not treatments, aligning financial incentives with successful outcomes. Gaia’s model is built on millions of data points from patients spanning 155 nationalities across 4 continents, and its AI continuously improves as more families are built.

Proven Model with Measurable Impact

Since launching in 2022, Gaia has delivered measurable results, with a baby born every 2.6 days. Now, together with Valar Ventures joining its investor roster, Gaia is focusing on scaling its operations in the US—the largest global fertility market valued at USD 20bn. The company’s financing model reduces costs by up to 50%, expanding accessibility and potentially unlocking a fivefold increase in market size.

“Gaia is redefining fertility care by solving critical affordability challenges with an outcome-based model that empowers patients, clinics, and insurers alike,” said Julian Kappus, Co-CEO at Heliad. “We see this partnership as an exciting opportunity to work closely with Gaia’s team, leveraging our complementary skill set to further develop and structure the complex financial elements of their innovative model.”

Investment to Fuel Expansion and Innovation

The additional funding will enable Gaia to:

  • Besides scaling its US operations, expanding into adjacent services like surrogacy and adoption to address the entire fertility journey.
  • Further enhance its AI capabilities, improving outcomes and customer satisfaction.
  • Strengthen its partnerships with clinics and insurers to maximize accessibility for underserved demographics.

About Heliad
Heliad (Stock ticker A7A, ISIN DE0001218063) is a listed investment company with a mission to empower both entrepreneurs and investors. The company invests in market leading companies across various verticals and regions to power their next phase of growth. As a listed company and through our strong team and strategic partners, Heliad can support companies pre, at and post IPO and act as a gateway to public equity capital markets. An evergreen structure positions Heliad to act independently of usual fund lifecycles, while providing shareholders with proprietary access to pre-IPO market returns without limitations on investment size or terms. For more information about Heliad, please visit www.heliad.com and follow on LinkedIn to stay updated.


Contact:
Heliad AG
Tel: +49 69 719 12 80 00
E-Mail: investor-relations@heliad.com


28.01.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Heliad AG
Ulmenstraße 37-39
60325 Frankfurt/Main
Germany
Phone: +49 (0)69 719 12 80 - 00
Fax: +49 (0)69 719 12 80 - 999
E-mail: investor-relations@heliad.com
Internet: www.heliad.com
ISIN: DE0001218063
WKN: 121806
Indices: Basic Board
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2076513

 
End of News EQS News Service

2076513  28.01.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2076513&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu FinLab AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Sprung ins kalte Wasser – Deniz Kayadelen zu Gast im BX Morningcall mit François Bloch

🚨 Eisige Rekorde & High-Performance im Business! 🚨

In dieser Folge des BX Morningcall zu Gast: Denise Kayadelen, sechsfache Weltmeisterin im Eisschwimmen 🏊‍♀️❄️, Gründerin & Speaker von «Out of Comfort Zone» und Bestseller Autorin.

Zusammen mit dem Investmentstrategen François Bloch und David Kunz, COO der BX Swiss, sprich Deniz Kayadelen :
👉 Wie sie es schafft, bei bis zu 1°C Bestzeiten zu schwimmen und gleichzeitig CEOs weltweit zu coachen?
👉 Warum «Raus aus der Komfortzone» ihr Lebensmotto ist – ob im Wasser, im Beruf oder im Alltag?
👉 Und was ein verrückter Roadtrip zum Nordkap mit ihrer Leidenschaft zu tun hat? 🚗🌊

👉🏽 https://bxplus.ch/bx-musterportfolio/

Sprung ins kalte Wasser – Deniz Kayadelen zu Gast im BX Morningcall mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’047.01 19.91 UUGBSU
Short 13’345.58 13.49 BHDSPU
Short 13’813.22 8.96 U5BSSU
SMI-Kurs: 12’530.32 29.01.2025 17:30:32
Long 12’040.00 19.97
Long 11’754.45 13.71 BQES7U
Long 11’238.74 8.80 SSRM9U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

FinLab AG 10.50 0.00% FinLab AG

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten